SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Crystalys Therapeutics, a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced ...
Editas Medicine EDIT reported new positive data from the phase I/II/III RUBY study of its lead candidate, reni-cel, in 18 patients with sickle cell disease (SCD) and the phase I/II EdiTHAL study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results